FDA Investigates Potential FM Drug
Friday, May 16, 2008
FMOnline, vol. 8, no. 5
Recently the US Food and Drug Administration opened an
Investigational New Drug Application to conduct a double-blind,
randomized, placebo-controlled Phase II clinical trial of oral
flupirtine for the treatment of fibromyalgia. Approved as a treatment
of pain in Europe since 1981, oral flupirtine—a non-opiate
analgesic—has never been approved for any indication in the United
States. Used for post-surgical pain, cancer pain, trauma pain, pain
associated with liver disease, and other nocioceptive pain states, oral
flupirtine is anticipated to be effective for neuropathic pain since it
acts in the central nervous system. It is also said to exhibit no known
abuse potential and to lack withdrawal effects.
I did some research on flupirtine. This is one awesome drug. It's already been proven to work on FM from at least one report.